A tumor biomarker is a molecular or process-based change that reflects the status of an
underlying malignancy. A tumor biomarker may be identified and measured by one or more …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Cirrhosis
caused by hepatitis B virus, hepatitis C virus or chronic alcohol intake is associated with …

Tumour markers could be helpful along the continuum of care for patients with
hepatocellular carcinoma; however, there is insufficient data for routine use of most current …

Hepatocellular carcinoma (HCC) is responsible for a large proportion of cancer deaths
worldwide. HCC is frequently diagnosed after the development of clinical deterioration at …

Globally, up to approximately 800,000 new cases of hepatocellular carcinoma (HCC) are
diagnosed annually. 1, 2 The incidence of cirrhosis-related HCC is rising in the United …

Hepatocellular carcinoma (HCC), one of the most common cancers worldwide, usually
develops in a liver already suffering from chronic damages, often cirrhosis. There has been …

Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this
disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage …

Chronic hepatitis B virus (HBV) infected patients have an almost 100-fold increased risk to
develop hepatocellular carcinoma (HCC). HCC is the fifth most common and third most …

Purpose Early detection of hepatocellular carcinoma (HCC) is essential for improved
prognosis and long-term survival. To date, screening for HCC depends on serological …

Background Tumor markers in the early detection of tumors are promising tools that could
improve the control and treatment of tumors. While alpha-fetoprotein (AFP) is a commonly …